SHARE CAPITAL AND OTHER EQUITY INSTRUMENTS (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF STOCK OPTION

A summary of the stock option activity under the Company’s incentive plan for the years ended December 31, 2024 and 2023 is presented below:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Grant Date Fair Value		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding at January 1, 2023		3,222		$	555.75	$	672.30		4.1	$	—
Granted		—			—		—				—
Forfeited		(1,200	)		46.05		38.70				—
Outstanding at December 31, 2023		2,022			857.55		1,158.30		3.4		—
Granted		—			—		—				—
Forfeited		(484	)		590.25		810.30				—
Outstanding at December 31, 2024		1,538		$	941.55	$	1,267.65		2.3	$	—
Exercisable at December 31, 2024		1,487		$	972.42	$	1,310.20		2.0	$	—

SCHEDULE OF STOCK-BASED COMPENSATION FOR RESTRICTED STOCK UNITS

The following table summarizes the Company’s recognition of stock-based compensation for restricted stock units for the following periods:

	Year ended December 31,
	2024		2023
Stock-based compensation expense for RSUs:
General and administrative	$	646,636	$	1,085,791
Research and development		829,311		908,294
Total	$	1,475,947	$	1,994,085

SCHEDULE OF WARRANTS OUTSTANDING

The following table summarizes information about shares issuable under warrants outstanding at December 31, 2024 and 2023:

	Warrant shares outstanding			Weighted average exercise price		Weighted average remaining life		Intrinsic value
Outstanding at January 1, 2023		43,698		$	875.40		3.6	$	5,514
Issued		154,088			20.55		—		—
Exercised		(8,134	)		20.55		—		—
Forfeited		(3,038	)		1,672.50				—
Outstanding at December 31, 2023		186,614			176.85		4.6		—
Issued		—			—		—		—
Expired		(39	)		2,400.00		—		—
Exercised		(130,267	)		20.55		—		—
Outstanding at December 31, 2024		56,308		$	536.70		2.7	$	—
Exercisable at December 31, 2024		56,308		$	536.70		2.7	$	—

SCHEDULE OF INVESTMENT OPTIONS

The following table summarizes information about investment options outstanding at December 31, 2024 and 2023:

	Investment options outstanding			Weighted average exercise price		Weighted average remaining life		Intrinsic value
Outstanding at January 1, 2023		71,334		$	118.95		5.1	$	—
Exercised		(66,667	)		20.55		—		—
Outstanding at December 31, 2023		4,667			150.00		4.1	$	—
Exercised		—			—		—		—
Outstanding at December 31, 2024		4,667		$	150.00		2.6	$	—
Exercisable at December 31, 2024		4,667		$	150.00		2.6	$	—

SCHEDULE OF BLACK SCHOLES VALUATION MODEL FOR VALUATION OF WARRANTS

The Company established the initial fair value of its equity classified Inducement Warrants at the date of issuance on December 28, 2023. The Company used a Black Scholes valuation model in order to determine their value. The key inputs into the Black Scholes valuation model for the valuation of the warrants are below:

	Roth and Inducement Warrants
	December 28, 2023
Term (years)		5.0
Stock price	$	23.40
Exercise price	$	20.55
Dividend yield		—	%
Expected volatility		92.0	%
Risk free interest rate		3.80	%
Number of warrants		154,088
Value (per share)	$	17.40

Restricted Stock Units (RSUs) [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF RESTRICTED STOCK UNITS

The Company’s activity in restricted stock units was as follows for the year ended December 31, 2024:

	Number of shares			Weighted average fair value
Non-vested at January 1, 2023		4,271		$	1,388.55
Granted		12,167			40.95
Forfeited		(2,896	)		385.80
Vested		(4,176	)		297.00
Non-vested at December 31, 2023		9,366			434.55
Granted		42,543			8.84
Forfeited		(1,850	)		43.05
Vested		(2,042	)		333.30
Non-vested at December 31, 2024		48,017		$	24.08

Restricted Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

SCHEDULE OF RESTRICTED STOCK UNITS

The Company’s activity in restricted common stock was as follows for the years ended December 31, 2024:

	Number of shares			Weighted average fair value
Non-vested at January 1, 2024		—			—
Granted		14,586		$	6.30
Vested		(14,586	)	$	6.30
Non-vested at December 31, 2024		—		$	—